{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:13:09Z","timestamp":1790172789525,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T00:00:00Z","timestamp":1617321600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00c3\u00a9dicale","doi-asserted-by":"publisher","award":["PME20180639496"],"award-info":[{"award-number":["PME20180639496"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"publisher","award":["FDF\/2014 00047970"],"award-info":[{"award-number":["FDF\/2014 00047970"]}],"id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007380","name":"Fondation de l'Avenir pour la Recherche M\u00c3\u00a9dicale Appliqu\u00c3\u00a9e","doi-asserted-by":"publisher","award":["AP-RM-18-017"],"award-info":[{"award-number":["AP-RM-18-017"]}],"id":[{"id":"10.13039\/100007380","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.acvd.2020.01.002","type":"journal-article","created":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T12:55:06Z","timestamp":1583931306000},"page":"285-292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Cardiac cell therapy: Current status, challenges and perspectives"],"prefix":"10.1016","volume":"113","author":[{"given":"Philippe","family":"Menasch\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acvd.2020.01.002_bib0245","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4252\/wjsc.v9.i4.68","article-title":"Fifteen years of bone marrow mononuclear cell therapy in acute myocardial infarction","volume":"9","author":"Micheu","year":"2017","journal-title":"World J Stem Cells"},{"key":"10.1016\/j.acvd.2020.01.002_bib0250","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/35070587","article-title":"Bone marrow cells regenerate infarcted myocardium","volume":"410","author":"Orlic","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.acvd.2020.01.002_bib0255","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1161\/CIRCRESAHA.118.313593","article-title":"No Risk. No Reward","volume":"123","author":"Tyler","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.acvd.2020.01.002_bib0260","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1161\/CIRCRESAHA.116.310340","article-title":"What is the future of cell-based therapy for acute myocardial infarction","volume":"120","author":"Tompkins","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.acvd.2020.01.002_bib0265","first-page":"CD007888","article-title":"Stem cell therapy for chronic ischaemic heart disease and congestive heart failure","volume":"12","author":"Fisher","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.acvd.2020.01.002_bib0270","first-page":"648","article-title":"Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial","volume":"38","author":"Bartunek","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2020.01.002_bib0275","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1002\/ejhf.898","article-title":"Benefit of cardiopoietic mesenchymal stem cell therapy on left ventricular remodelling: results from the Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) study","volume":"19","author":"Teerlink","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.acvd.2020.01.002_bib0280","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1161\/CIRCULATIONAHA.110.971622","article-title":"Characterization and functionality of cardiac progenitor cells in congenital heart patients","volume":"123","author":"Mishra","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2020.01.002_bib0285","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jacc.2017.11.047","article-title":"Transplantation of human embryonic stem cell-derived cardiovascular progenitors for severe ischemic left ventricular dysfunction","volume":"71","author":"Menasche","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2020.01.002_bib0290","first-page":"e5585","article-title":"Efficacy and safety of stem cell therapy in advanced heart failure patients: a systematic review with a meta-analysis of recent trials between 2017 and 2019","volume":"11","author":"Jayaraj","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.acvd.2020.01.002_bib0295","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/CIRCRESAHA.116.309782","article-title":"A deep proteome analysis identifies the complete secretome as the functional unit of human cardiac progenitor cells","volume":"120","author":"Sharma","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.acvd.2020.01.002_bib0300","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.stem.2013.05.008","article-title":"Cardiac stem cell therapy and the promise of heart regeneration","volume":"12","author":"Garbern","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.acvd.2020.01.002_bib0305","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/CIRCRESAHA.108.176826","article-title":"Paracrine mechanisms in adult stem cell signalling and therapy","volume":"103","author":"Gnecchi","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.acvd.2020.01.002_bib0310","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nature13233","article-title":"Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts","volume":"510","author":"Chong","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.acvd.2020.01.002_bib0315","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nbt.4162","article-title":"Human embryonic stem cell-derived cardiomyocytes restore function in infarcted hearts of non-human primates","volume":"36","author":"Liu","year":"2018","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.acvd.2020.01.002_bib0320","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nature19815","article-title":"Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts","volume":"538","author":"Shiba","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.acvd.2020.01.002_bib0325","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nbt.1516","article-title":"Characterization of human embryonic stem cells with features of neoplastic progression","volume":"27","author":"Werbowetski-Ogilvie","year":"2009","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.acvd.2020.01.002_bib0330","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/cr.2013.102","article-title":"Highly efficient induction and long-term maintenance of multipotent cardiovascular progenitors from human pluripotent stem cells under defined conditions","volume":"23","author":"Cao","year":"2013","journal-title":"Cell Res"},{"key":"10.1016\/j.acvd.2020.01.002_bib0335","first-page":"701","article-title":"Experimental","volume":"120","author":"Agarwal","year":"2017","journal-title":"Systems and computational approaches to understanding the MicroRNA-mediated reparative potential of cardiac progenitor cell-derived exosomes from pediatric patients. Circ Res"},{"key":"10.1016\/j.acvd.2020.01.002_bib0340","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1093\/eurheartj\/ehy012","article-title":"Acellular therapeutic approach for heart failure: in vitro production of extracellular vesicles from human cardiovascular progenitors","volume":"39","author":"El Harane","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2020.01.002_bib0345","doi-asserted-by":"crossref","first-page":"29933","DOI":"10.1038\/srep29933","article-title":"The myocardial regenerative potential of three-dimensional engineered cardiac tissues composed of multiple human iPS cell-derived cardiovascular cell lineages","volume":"6","author":"Masumoto","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.acvd.2020.01.002_bib0350","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.biopha.2018.05.066","article-title":"Carbon nanotube scaffolds as emerging nanoplatform for myocardial tissue regeneration: A review of recent developments and therapeutic implications","volume":"104","author":"Gorain","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.acvd.2020.01.002_bib0355","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1172\/JCI80575","article-title":"Hurdles to clinical translation of human induced pluripotent stem cells","volume":"125","author":"Neofytou","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.acvd.2020.01.002_bib0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2019.02.005","article-title":"Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with enhanced immune compatibility","volume":"24","author":"Xu","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.acvd.2020.01.002_bib0365","doi-asserted-by":"crossref","first-page":"34478","DOI":"10.1038\/srep34478","article-title":"Neural stem cell tumorigenicity and biodistribution assessment for phase i clinical trial in Parkinson's Disease","volume":"6","author":"Garitaonandia","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.acvd.2020.01.002_bib0370","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.stemcr.2017.02.003","article-title":"Fail-safe system against potential tumorigenicity after transplantation of iPSC derivatives","volume":"8","author":"Itakura","year":"2017","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.acvd.2020.01.002_bib0375","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41586-018-0733-7","article-title":"Linking a cell-division gene and a suicide gene to define and improve cell therapy safety","volume":"563","author":"Liang","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.acvd.2020.01.002_bib0380","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.stemcr.2019.04.005","article-title":"Human embryonic stem cell-derived cardiomyocytes regenerate the infarcted pig heart but induce ventricular tachyarrhythmias","volume":"12","author":"Romagnuolo","year":"2019","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.acvd.2020.01.002_bib0385","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.scr.2014.04.010","article-title":"Harnessing Hippo in the heart: Hippo\/Yap signalling and applications to heart regeneration and rejuvenation","volume":"13","author":"Lin","year":"2014","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.acvd.2020.01.002_bib0390","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1161\/CIRCULATIONAHA.116.024692","article-title":"Chemical enhancement of in vitro and in vivo direct cardiac reprogramming","volume":"135","author":"Mohamed","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2020.01.002_bib0395","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCRESAHA.116.304872","article-title":"Similar effect of autologous and allogeneic cell therapy for ischemic heart disease: systematic review and meta-analysis of large animal studies","volume":"116","author":"Jansen Of Lorkeers","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.acvd.2020.01.002_bib0400","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/cvr\/cvy055","article-title":"Cardioprotection by cardiac progenitor cell-secreted exosomes: role of pregnancy-associated plasma protein-A","volume":"114","author":"Barile","year":"2018","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.acvd.2020.01.002_bib0405","doi-asserted-by":"crossref","first-page":"e6005","DOI":"10.1371\/journal.pone.0006005","article-title":"Cell therapy attenuates cardiac dysfunction post myocardial infarction: effect of timing, routes of injection and a fibrin scaffold","volume":"4","author":"Nakamuta","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.acvd.2020.01.002_bib0410","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1002\/adma.201505349","article-title":"Biomaterial-enhanced cell and drug delivery: lessons learned in the cardiac field and future perspectives","volume":"28","author":"O\u2019Neill","year":"2016","journal-title":"Adv Mater"},{"key":"10.1016\/j.acvd.2020.01.002_bib0415","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.healun.2018.11.002","article-title":"Development of a transplant injection device for optimal distribution and retention of human induced pluripotent stem cellderived cardiomyocytes","volume":"38","author":"Tabei","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.acvd.2020.01.002_bib0420","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/nmat4956","article-title":"Flexible shape-memory scaffold for minimally invasive delivery of functional tissues","volume":"16","author":"Montgomery","year":"2017","journal-title":"Nat Mater"},{"key":"10.1016\/j.acvd.2020.01.002_bib0425","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/s41551-018-0247-5","article-title":"Sustained release of targeted cardiac therapy with a replenishable implanted epicardial reservoir","volume":"2","author":"Whyte","year":"2018","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.acvd.2020.01.002_bib0430","doi-asserted-by":"crossref","first-page":"e012351","DOI":"10.1161\/JAHA.119.012351","article-title":"Intravascular stem cell bioreactor for prevention of adverse remodelling after myocardial infarction","volume":"8","author":"Johnston","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.acvd.2020.01.002_bib0435","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/cvr\/cvy067","article-title":"Sustained release of endothelial progenitor cell-derived extracellular vesicles from shear-thinning hydrogels improves angiogenesis and promotes function after myocardial infarction","volume":"114","author":"Chen","year":"2018","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.acvd.2020.01.002_bib0440","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.actbio.2017.12.025","article-title":"Stem cell-inspired secretome-rich injectable hydrogel to repair injured cardiac tissue","volume":"69","author":"Waters","year":"2018","journal-title":"Acta Biomater"},{"key":"10.1016\/j.acvd.2020.01.002_bib0445","first-page":"7","article-title":"Repeated administrations of cardiac progenitor cells are superior to a single administration of an equivalent cumulative dose","author":"Tang","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.acvd.2020.01.002_bib0450","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.stem.2009.05.003","article-title":"Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6","volume":"5","author":"Lee","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.acvd.2020.01.002_bib0455","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/CIRCRESAHA.117.310599","article-title":"Intravenously delivered mesenchymal stem cells: systemic anti-inflammatory effects improve left ventricular dysfunction in acute myocardial infarction and ischemic cardiomyopathy","volume":"120","author":"Luger","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.acvd.2020.01.002_bib0460","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/CIRCRESAHA.117.310712","volume":"121","author":"Bartolucci","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.acvd.2020.01.002_bib0465","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/CIRCRESAHA.118.313251","article-title":"New paradigms in cell therapy: repeated dosing, intravenous delivery. immunomodulatory actions, and new cell types","volume":"123","author":"Wysoczynski","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.acvd.2020.01.002_bib0470","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1016\/j.bbrc.2018.08.012","article-title":"Intravenous mesenchymal stem cell-derived exosomes ameliorate myocardial inflammation in the dilated cardiomyopathy","volume":"503","author":"Sun","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.acvd.2020.01.002_bib0475","first-page":"20","article-title":"Exosomal expression of CXCR4 targets cardioprotective vesicles to myocardial infarction and improves outcome after systemic administration","author":"Ciullo","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.acvd.2020.01.002_bib0480","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1002\/stem.1806","article-title":"Are clinical trials with mesenchymal stem\/progenitor cells too far ahead of the science? Lessons from experimental hematology","volume":"32","author":"Prockop","year":"2014","journal-title":"Stem Cells"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213620300401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213620300401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:45:46Z","timestamp":1761745546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875213620300401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S1875213620300401"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2020.01.002","relation":{},"ISSN":["1875-2136"],"issn-type":[{"value":"1875-2136","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac cell therapy: Current status, challenges and perspectives","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2020.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}